rs200392453
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001378609.3(OTOGL):āc.3566A>Gā(p.Gln1189Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000683 in 1,613,040 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.00028 ( 0 hom., cov: 32)
Exomes š: 0.00072 ( 1 hom. )
Consequence
OTOGL
NM_001378609.3 missense
NM_001378609.3 missense
Scores
3
10
3
Clinical Significance
Conservation
PhyloP100: 8.86
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.3566A>G | p.Gln1189Arg | missense_variant | 31/59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.3566A>G | p.Gln1189Arg | missense_variant | 31/59 | 5 | NM_001378609.3 | ENSP00000447211 | P1 | |
OTOGL | ENST00000646859.1 | c.3431A>G | p.Gln1144Arg | missense_variant | 35/63 | ENSP00000496036 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152180Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
43
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000227 AC: 56AN: 246484Hom.: 0 AF XY: 0.000202 AC XY: 27AN XY: 133870
GnomAD3 exomes
AF:
AC:
56
AN:
246484
Hom.:
AF XY:
AC XY:
27
AN XY:
133870
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000725 AC: 1059AN: 1460742Hom.: 1 Cov.: 31 AF XY: 0.000711 AC XY: 517AN XY: 726696
GnomAD4 exome
AF:
AC:
1059
AN:
1460742
Hom.:
Cov.:
31
AF XY:
AC XY:
517
AN XY:
726696
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000282 AC: 43AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74464
GnomAD4 genome
AF:
AC:
43
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
4
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
25
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 16, 2020 | The p.Gln1180Arg variant in OTOGL has been previously reported by our laboratory in 1 individual with hearing loss; however, a variant affecting the remaining copy of OTOGL was not identified. It has been identified in 0.04% (56/125812) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org/). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Gln1180Arg variant is uncertain. ACMG/AMP Criteria applied: PP3, PM2_Supporting. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 08, 2021 | This variant is present in population databases (rs200392453, ExAC 0.03%). This sequence change replaces glutamine with arginine at codon 1180 of the OTOGL protein (p.Gln1180Arg). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and arginine. This variant has not been reported in the literature in individuals with OTOGL-related conditions. ClinVar contains an entry for this variant (Variation ID: 504850). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | OTOGL: PM2, BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 07, 2021 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.3539A>G (p.Q1180R) alteration is located in exon 30 (coding exon 30) of the OTOGL gene. This alteration results from a A to G substitution at nucleotide position 3539, causing the glutamine (Q) at amino acid position 1180 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Autosomal recessive nonsyndromic hearing loss 84B Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 11, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;.;T
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
T
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
.;.;D
REVEL
Pathogenic
Sift
Uncertain
.;.;D
Sift4G
Uncertain
.;.;D
Vest4
0.66
MVP
0.71
MPC
0.19
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at